367 related articles for article (PubMed ID: 22710102)
1. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.
Duan YT; Wang ZC; Sang YL; Tao XX; Teraiya SB; Wang PF; Wen Q; Zhou XJ; Ding L; Yang YH; Zhu HL
Eur J Med Chem; 2014 Apr; 76():387-96. PubMed ID: 24594526
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors.
Luo Y; Zhang LR; Hu Y; Zhang S; Fu J; Wang XM; Zhu HL
ChemMedChem; 2012 Sep; 7(9):1587-93. PubMed ID: 22811397
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a novel class of some 1,3,4-oxadiazole derivatives as antimicrobial agents.
Chikhalia KH; Vashi DB; Patel MJ
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):617-22. PubMed ID: 18642158
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
11. Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis.
Wang ZC; Duan YT; Qin YJ; Wang PF; Luo Y; Wen Q; Yang YA; Sun J; Hu Y; Sang YL; Zhu HL
Eur J Med Chem; 2013 Jul; 65():456-63. PubMed ID: 23770447
[TBL] [Abstract][Full Text] [Related]
12. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
Segretti ND; Serafim RA; Segretti MC; Miyata M; Coelho FR; Augusto O; Ferreira EI
Bioorg Med Chem Lett; 2016 Aug; 26(16):3988-93. PubMed ID: 27426865
[TBL] [Abstract][Full Text] [Related]
13. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Li HQ; Luo Y; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
Li ZL; Li QS; Zhang HJ; Hu Y; Zhu DD; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4413-20. PubMed ID: 21752655
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
Qin YJ; Wang PF; Makawana JA; Wang ZC; Wang ZN; Yan-Gu ; Jiang AQ; Zhu HL
Bioorg Med Chem Lett; 2014 Nov; 24(22):5279-83. PubMed ID: 25587588
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles.
Letafat B; Emami S; Aliabadi A; Mohammadhosseini N; Moshafi MH; Asadipour A; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2008 Aug; 341(8):497-501. PubMed ID: 18618489
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
Cheng K; Xue JY; Zhu HL
Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.
Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL
Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]